Atrás
11
También listada como
NURAF
OTC
Rango del Día
$26.50
$27.01
Rango de 52 Semanas
$22.73
$43.20
Volumen
19,178
Promedio 50D / 200D
$30.22
/
$36.84
Cierre Anterior
$27.39
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Technology (621 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 0.2 | 12.3 |
| P/B | 0.0 | 2.9 |
| ROE % | 22.5 | 8.9 |
| Net Margin % | 12.3 | 5.6 |
| Rev Growth 5Y % | 8.6 | 9.2 |
| D/E | 0.6 | 0.3 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$214.48
$209.78 – $217.61
|
870 B | 1 |
| FY2026 |
$181.60
$180.03 – $183.17
|
810 B | 1 |
Puntos Clave
Revenue grew 8.58% annually over 5 years — modest growth
Earnings grew 17.73% over the past year
ROE of 22.50% indicates high profitability
Generating 80.59B in free cash flow
P/E of 0.16 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.74%
Crecimiento
Revenue Growth (5Y)
8.58%
Revenue (1Y)3.84%
Earnings (1Y)17.73%
FCF Growth (3Y)12.04%
Calidad
Return on Equity
22.50%
ROIC14.35%
Net Margin12.26%
Op. Margin17.64%
Seguridad
Debt / Equity
0.62
Current Ratio1.75
Interest Coverage23.25
Valoración
P/E Ratio
0.16
P/B Ratio0.04
EV/EBITDA0.87
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.84% | Revenue Growth (3Y) | 5.12% |
| Earnings Growth (1Y) | 17.73% | Earnings Growth (3Y) | 10.85% |
| Revenue Growth (5Y) | 8.58% | Earnings Growth (5Y) | 15.40% |
| Profitability | |||
| Revenue (TTM) | 764.81B | Net Income (TTM) | 93.76B |
| ROE | 22.50% | ROA | 10.10% |
| Gross Margin | 36.00% | Operating Margin | 17.64% |
| Net Margin | 12.26% | Free Cash Flow (TTM) | 80.59B |
| ROIC | 14.35% | FCF Growth (3Y) | 12.04% |
| Safety | |||
| Debt / Equity | 0.62 | Current Ratio | 1.75 |
| Interest Coverage | 23.25 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 0.16 | P/B Ratio | 0.04 |
| P/S Ratio | 0.02 | PEG Ratio | 1.52 |
| EV/EBITDA | 0.87 | Dividend Yield | 0.01% |
| Market Cap | 15.19B | Enterprise Value | 117.62B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 764.81B | 736.56B | 692.17B | 611.63B | 550.34B |
| Net Income | 93.76B | 79.64B | 76.31B | 71.45B | 52.87B |
| EPS (Diluted) | 163.56 | 136.84 | 128.88 | 120.34 | 88.12 |
| Gross Profit | 275.30B | 261.01B | 239.83B | 216.07B | 185.80B |
| Operating Income | 134.91B | 120.41B | 111.83B | 102.54B | 87.43B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 928.50B | 922.77B | 838.22B | 789.66B | 656.54B |
| Total Liabilities | 490.54B | 519.75B | 435.81B | 447.17B | 323.33B |
| Shareholders' Equity | 434.04B | 399.53B | 399.01B | 339.36B | 330.50B |
| Total Debt | 271.02B | 298.54B | 237.74B | 250.42B | 165.59B |
| Cash & Equivalents | 168.60B | 173.94B | 129.26B | 115.61B | 153.19B |
| Current Assets | 419.42B | 405.18B | 349.10B | 333.65B | 323.37B |
| Current Liabilities | 239.48B | 214.64B | 198.25B | 298.34B | 174.35B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#534 of 670
Actividad Reciente
Entró
Contrarian Investing (David Dreman)
Mar 24, 2026